Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.50 and traded as high as $0.62. Xtant Medical shares last traded at $0.60, with a volume of 342,448 shares trading hands.
Xtant Medical Stock Up 14.7%
The company has a current ratio of 2.12, a quick ratio of 0.88 and a debt-to-equity ratio of 0.42. The company has a market capitalization of $82.93 million, a price-to-earnings ratio of -4.59 and a beta of 0.35. The firm’s fifty day simple moving average is $0.47 and its two-hundred day simple moving average is $0.50.
Hedge Funds Weigh In On Xtant Medical
A hedge fund recently raised its stake in Xtant Medical stock. Renaissance Technologies LLC lifted its stake in Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT – Free Report) by 15.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 798,033 shares of the medical device company’s stock after acquiring an additional 103,825 shares during the quarter. Renaissance Technologies LLC owned 0.57% of Xtant Medical worth $354,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 69.33% of the company’s stock.
About Xtant Medical
Xtant Medical Holdings, Inc provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.
Further Reading
- Five stocks we like better than Xtant Medical
- Canada Bond Market Holiday: How to Invest and Trade
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Why Boeing May Be Ready to Take Off After Latest Developments
- Canadian Penny Stocks: Can They Make You Rich?
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.
